IGF-1 reference ranges: understanding your result

Keep the complete laboratory report

A screenshot containing only a number leaves out information needed for interpretation. Keep the date, units, laboratory, reference interval, and any standard deviation score provided. Your clinician needs to know whether the result was obtained before treatment or during an established plan.

Reference intervals describe the values used for comparison; they are not personal performance grades. Being near one end does not, by itself, establish disease or a need to move toward the other end.

Ask which clinical question the test is intended to answer. Screening an endocrine concern, monitoring an established treatment, and evaluating an unexplained symptom are different uses. The result becomes more meaningful when the question is clear before it is interpreted.

Consider a hypothetical result marked normal by one laboratory but compared online with a higher target from another source. The disagreement does not tell you which treatment to take. It tells you to establish whether the units, reference population, and assay match, and whether the online target has clinical support. A clinician should resolve that comparison before interpreting the difference as a deficiency.

Why two laboratories may not agree perfectly

In a study of 911 healthy adults aged 18–90, investigators compared six IGF-I immunoassays and developed age- and sex-related reference data. The assays did not produce interchangeable results, even when assessed using standardized scores.

That finding matters if a follow-up test comes from a different laboratory or method. An apparent change may not represent a simple treatment effect. Ask the ordering clinician whether the results are directly comparable before drawing conclusions from the difference.

This does not make testing useless. It means a careful monitoring plan should preserve the context of each measurement. The laboratory method is part of the evidence, just as the units and collection date are.

Age adjustment is not an invitation to target youth

An age-related reference range helps clinicians compare a result with an appropriate reference population. It does not show that an older adult will become healthier by reaching a younger adult’s number.

That distinction is easy to lose when a clinic markets hormone optimization. To justify a target, ask what clinical outcome it has been shown to improve in people like you, and what risks or tradeoffs were assessed. A youthful-looking chart is not the same as an outcome study.

A treatment can change a laboratory marker without changing how you function or feel. Conversely, symptoms deserve attention even when a result is within range. Neither situation should be reduced to chasing a single number.

A standardized score still needs context

A standard deviation score expresses a result relative to a reference distribution. It can make an age-related comparison easier to describe, but it does not turn the measurement into a diagnosis or remove all differences between assays.

Ask the clinician to translate any score into plain language: what does it suggest, how confident is the interpretation, and what would happen next? Do not assume that a score supplied by an online calculator matches the laboratory’s own method.

When deficiency is being considered, the Endocrine Society guideline emphasizes a broader diagnostic process. An IGF-1 result is one piece of that process. Our diagnosis guide explains why additional evaluation may be needed.

Use trends to support a decision

For follow-up, bring the whole sequence of reports and a concise record of symptoms, medication changes, and the treatment goal. Ask whether any apparent trend is large enough and consistent enough to change the plan.

It helps to separate two questions: is the treatment producing a biological response, and is it producing a worthwhile clinical benefit? Both deserve answers. A rising number should not be allowed to answer the second question automatically.

If a result is flagged as abnormal, contact the clinician responsible for interpreting it instead of changing your prescription yourself. Ask for the next step and the reason for it. Clear interpretation should reduce uncertainty, not leave you trying to manage a hormone target alone.